# FDA Inspection 1251812 - medac Gesellschaft fur klinische Spezialpraparate m.b.H. - August 12, 2021

Source: https://www.keypedia.com/records/fda_inspections/medac-gesellschaft-fur-klinische-spezialpraparate-mbh/6f8db3de-4ccd-4d5e-819b-b89e22c6c740
Source feed: FDA_Inspections

> FDA Inspection 1251812 for medac Gesellschaft fur klinische Spezialpraparate m.b.H. on August 12, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251812
- Company Name: medac Gesellschaft fur klinische Spezialpraparate m.b.H.
- Inspection Date: 2021-08-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1304554 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/medac-gesellschaft-fur-klinische-spezialpraparate-mbh/60b554ad-b696-4b4b-91af-c7325e57539a)
- [FDA Inspection 1304554 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/medac-gesellschaft-fur-klinische-spezialpraparate-mbh/318709fa-5aad-4b89-945b-6b73b2772feb)

Company: https://www.keypedia.com/companies/medac-gesellschaft-fur-klinische-spezialpraparate-mbh/81c62da5-94a0-4da1-b952-5c33171cdce3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c